These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7904701)

  • 41. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
    Mizutani S
    Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mycobacterium avium infection in a patient with AIDS].
    Sánchez Ayuso J; Mateo Alvarez S
    An Med Interna; 2002 Feb; 19(2):101. PubMed ID: 11989091
    [No Abstract]   [Full Text] [Related]  

  • 43. How to treat bacteraemic Mycobacterium avium complex disease.
    Chin DP; Hopewell PC
    Lancet; 1995 Oct; 346(8980):920-1. PubMed ID: 7564723
    [No Abstract]   [Full Text] [Related]  

  • 44. Clarithromycin and MAC.
    AIDS Patient Care STDS; 1996 Feb; 10(1):54. PubMed ID: 11361673
    [No Abstract]   [Full Text] [Related]  

  • 45. A patient with refractory disseminated Mycobacterium avium after immune-reconstitution localized MAC.
    Jenny-Avital ER
    AIDS Clin Care; 2003 Mar; 15(3):24-6. PubMed ID: 12685419
    [No Abstract]   [Full Text] [Related]  

  • 46. [Mycobacterium avium complex infections: the point on the treatments].
    Brandissou S; Hamel B; Veillet B; Kinowski JM; Yagoubi N; Bressolle F
    Therapie; 1997; 52(1):65-71. PubMed ID: 9183925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rifabutin prevents campylobacter infection in patients with AIDS.
    Pulik M; Leturdu F; Lionnet F; Genet P; Petitdidier C; Touahri T
    Clin Infect Dis; 1996 Nov; 23(5):1197-8. PubMed ID: 8922840
    [No Abstract]   [Full Text] [Related]  

  • 48. [Significance of Mycobacterium avium-intracellulare Complex in infections (review of the literature)].
    Filipovskiĭ AV
    Probl Tuberk; 1999; (5):45-8. PubMed ID: 10565219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clarithromycin-induced mania in two patients with AIDS.
    Nightingale SD; Koster FT; Mertz GJ; Loss SD
    Clin Infect Dis; 1995 Jun; 20(6):1563-4. PubMed ID: 7548513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NIAID study rules out high-dose clarithromycin for AIDS-related MAC.
    AIDS Patient Care STDS; 1996 Oct; 10(5):313. PubMed ID: 11361534
    [No Abstract]   [Full Text] [Related]  

  • 51. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.
    Martínez E; Miró JM; González J; Mallolas J; Gatell JM
    AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.
    Benson CA
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S237-42. PubMed ID: 8204776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated cavitary pulmonary Mycobacterium avium complex infection in a patient with AIDS.
    Alisky JM; Schlesinger L
    Clin Infect Dis; 1998 Dec; 27(6):1542-3. PubMed ID: 9868684
    [No Abstract]   [Full Text] [Related]  

  • 54. Criteria for use of rifabutin in adult patients with human immunodeficiency virus (HIV)-associated disease.
    Fish N; Kass CL
    Am J Health Syst Pharm; 1996 Jul; 53(13):1598-9. PubMed ID: 8809283
    [No Abstract]   [Full Text] [Related]  

  • 55. New data suggest antibiotic clarithromycin is effective in prolonging life of AIDS patients.
    AIDS Patient Care STDS; 1996 Dec; 10(6):382-3. PubMed ID: 11361575
    [No Abstract]   [Full Text] [Related]  

  • 56. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial.
    Oldfield EC; Fessel WJ; Dunne MW; Dickinson G; Wallace MR; Byrne W; Chung R; Wagner KF; Paparello SF; Craig DB; Melcher G; Zajdowicz M; Williams RF; Kelly JW; Zelasky M; Heifets LB; Berman JD
    Clin Infect Dis; 1998 Mar; 26(3):611-9. PubMed ID: 9524832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of thalidomide against Mycobacterium avium complex.
    Vicente T; Ortega A; Muñoz P; Diaz MD; Bouza E
    Arch Intern Med; 1993 Feb; 153(4):534. PubMed ID: 8435034
    [No Abstract]   [Full Text] [Related]  

  • 59. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Don't have a MAC attack. How to fight AIDS-related MAC. National Institutes of Health.
    AIDS Alert; 1997 Feb; 12(2):suppl 2. PubMed ID: 11364037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.